SVB Leerink Starts Eledon Pharamceuticals (ELDN) at Outperform
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
SVB Leerink initiates coverage on Eledon Pharamceuticals (NASDAQ: ELDN) with a Outperform rating and a price target of $34.00.
Shares of Eledon Pharamceuticals closed at $15.50 yesterday.
You May Also Be Interested In
- UPDATE: B.Riley Reinstates Workhorse Group (WKHS) at Buy, 'Can Deliver Without the Post Office'
- Canaccord Genuity Starts Ramelius Resources (RMS:AU) (RMLRF) at Buy
- Berenberg Starts Knights Group Holdings plc (KGH:LN) at Hold